Flavia Pigliacelli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Journal: Dermatology and therapy
Published: March 11, 2026
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: August 12, 2025
Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study.
Journal: Clinical and experimental dermatology
Published: July 01, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
Journal: The Journal of dermatological treatment
Published: June 09, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.
Journal: International journal of dermatology
Published: May 21, 2025
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas.
Journal: Dermatology (Basel, Switzerland)
Published: November 22, 2024
Cutaneous manifestations associated with unknown HIV infection: a case report.
Journal: Dermatology reports
Published: October 31, 2024
Rapidly and successful improvement of nail psoriasis with risankizumab.
Journal: Clinical case reports
Published: August 31, 2023
Phototherapy and mycosis fungoides: what's new?
Journal: Dermatology reports
Published: August 23, 2023
Last Updated: 09/26/2026